Abstract:OBJECTIVE:To pursue the changes of cell morphology, expression of differentiation related markers, and proliferation cycles of brain tumor stem cells (BTSCs) after differentiation in vitro.METHODS:Tumor stem cells of the line CD133(+) were obtained from two specimens from one clinical case with anaplasia ependymocytoma during operation, one specimen being obtained during the first operation and then second specimen being obtained during the second operation 6 months later on the recurrent tumor. CD133(+) cells were acquired by using magnetic sorting and then cultured to differentiate in medium containing 10% fetal bovine serum. The morphology of the cells was observed under phase contrast microscope. Cells were collected respectively before differentiation and 3, 7, 10, and 21 days after the differentiation. The cell surface markers such as CD133, nestin, glial fibrillary acidic protein (GFAP), and beta-tubulin III were detected with flow cytometry. Proliferation cycles were examined before differentiation and in the 7th day after differentiation. Normal neural stem cells (NSCs) obtained from fetal brain tissues were used as controls.RESULTS:(1) The BTSCs were round shape at the beginning, then changed to short fusiform, polygon and long fusiform. Seven days later the cells reversed to short fusiform and round shape. The cells accumulated into cell spheres and floated in the culture medium again. While the NSCs differentiated along their routine rules. (2) Both the undifferentiated BTSCs and NSCs showed high level expression of CD133 and nestin. After differentiation the BTSCs expressed CD133 and nestin, the expression levels decreased first and then increased. The expression rates of CD133 and nestin were (3.65 +/- 0.17)% and (28.99 +/- 1.26)% in the 7th day, (14.63 +/- 1.16)% and (45.46 +/- 1.27)% in the 21st day. While the positive expression rate of GFAP was higher than that of beta-tubulin III. In the 10th day the NSCs under differentiation lost the expression of CD133 and nestin. The percentage of GFAP positive cells and beta-tubulin III positive cells were (88.94 +/- 1.23)% and (11.94 +/- 0.36)% respectively. (3) All undifferentiated BTSCs were hypodiploid. After differentiation majority of the BTSCs were hypodiploid or hyperdiploid, The percentages of S phase and G(2)-M phase cells in the BTSCs were higher than that in the NSCs. The cell composition of recrudescent BTSCs was more complex than that of the primary BTSCs. All NSCs were diploid whether differentiated or not. Most of the NSCs were G(0)-G(1) phase cells.CONCLUSION:The differentiation direction of BTSCs is quietly different from that of the NSCs. There is an obvious dysdifferentiation in BTSCs.

Correlation research between cancer stem cells and the pathological grades of neuroepithelial tumors

Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors.

[Correlative Study of Distribution of Brain Tumor Stem Cell with Micro-Vascular System].

Identification of Brain Tumor Stem Cells and Research on Their Characters of Proliferation and Drug-Resistance

Biological characterization of primary and recurrent brain tumor stem cells

Research on correlation between proliferative activity of brain tumor stem cells and tumor grading

Correlation study of proliferative activity of brain tumor stem cells and microvessel density

Proliferative Status of Tumor Stem Cells May Be Correlated with Malignancy Grade of Human Astrocytomas

Isolation, culture and biological characteristics of tumor stern cells in human brain glioblastoma

CD133 in Identifying Perivascular Niche of Glioma Stem Cells

Isolation and Identification of Cancer Stem Cells in Human Gliomas

Isolation of cancer stem cells from primary cervical carcinoma and identification of their biological characteristics

Differentiation profile of brain tumor stem cells: a comparative study with neural stem cells

Investigation on the Correlation Between Circulating Tumor Cells and Cancer Stem Cells in Patients with Breast Cancer

Correlation of Cancer Stem Cell Markers and Immune Cell Markers in Resected Non-Small Cell Lung Cancer

The pathological characteristics of glioma stem cell niches.

[Characteristics of Morphology, Differentiation Related Marker, and Proliferation Dynamics of Differentiated Brain Tumor Stem Cells in Vitro].

Expression of Stem Cell Markers:CD133 and Nestin in Gliomas of Different Malignancy and the Correlation with Patients’ Prognosis

Nestin and CD133: Valuable Stem Cell-Specific Markers for Determining Clinical Outcome of Glioma Patients.

Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15

The distribution of brain tumor stem cells from different pathological grade gliomas